» Articles » PMID: 29094420

Rationally Designed Chemically Modified Glycodendrimer Inhibits Streptococcus Suis Adhesin SadP at Picomolar Concentrations

Overview
Journal Chemistry
Specialty Chemistry
Date 2017 Nov 3
PMID 29094420
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Host cell surface carbohydrate receptors of bacterial adhesins are attractive targets in anti-adhesion therapy. The affinity of carbohydrate ligands with adhesins is usually found in the low μm range, which poses a problem for the design of effective inhibitors useful in therapy. In an attempt to increase the inhibitory power of carbohydrate ligands, we have combined the approach of chemical modification of ligands with their presentation as multivalent dendrimers in the design of an inhibitor of streptococcal adhesin SadP binding to its galactosyl-α1-4-galactose (galabiose) receptor. By using a phenylurea-modified galabiose-containing trisaccharide in a tetravalent dendrimeric scaffold, inhibition of adhesin at a low picomolar level was achieved. This study has resulted in one of the most potent inhibitors observed for bacterial adhesins and demonstrates a promising approach to develop anti-adhesives with the potential of practical applicability.

Citing Articles

Beyond Antibiotics: What the Future Holds.

Benyamini P Antibiotics (Basel). 2024; 13(10).

PMID: 39452186 PMC: 11504868. DOI: 10.3390/antibiotics13100919.


Multivalent Fucosides Targeting β-Propeller Lectins from Lung Pathogens with Promising Anti-Adhesive Properties.

Duca M, Haksar D, van Neer J, Thies-Weesie D, Martinez-Alarcon D, de Cock H ACS Chem Biol. 2022; 17(12):3515-3526.

PMID: 36414265 PMC: 9764287. DOI: 10.1021/acschembio.2c00708.


The binding mechanism of the virulence factor adhesin P subtype to globotetraosylceramide is associated with systemic disease.

Madar Johansson M, Belurier E, Papageorgiou A, Sundin A, Rahkila J, Kallonen T J Biol Chem. 2020; 295(42):14305-14324.

PMID: 32796033 PMC: 7573278. DOI: 10.1074/jbc.RA120.014818.


Novel Treatment Strategies for Biofilm-Based Infections.

Vuotto C, Donelli G Drugs. 2019; 79(15):1635-1655.

PMID: 31468316 DOI: 10.1007/s40265-019-01184-z.


Thiodigalactoside-Bovine Serum Albumin Conjugates as High-Potency Inhibitors of Galectin-3: An Outstanding Example of Multivalent Presentation of Small Molecule Inhibitors.

Zhang H, Laaf D, Elling L, Pieters R Bioconjug Chem. 2018; 29(4):1266-1275.

PMID: 29474087 PMC: 5909177. DOI: 10.1021/acs.bioconjchem.8b00047.